Healthcare could become a billion dollar a year market for Nvidia's number-crunching and artificial intelligence products, writes J.P. Morgan's semiconductor analyst Harlan Sur, in a note about the chip maker's Thursday presentation. Read More...
Motley Fool
3 Growth Stocks Poised for Huge Gains in 2023
Pharmaceutical companies Bayer (OTC: BAYR.Y), Eli Lilly (NYSE: LLY), and AstraZeneca (NASDAQ: AZN) had big years last year, bucking the rest of the market, and each stock saw share gains over the past year. All three companies have new drugs that were either recently launched or are likely to get final regulatory approval in 2023. Bayer’s stock is up more than 4.5% over the past year, thanks to strong financials and an even stronger pipeline.
Add Comment